Clinical tumour sequencing for precision oncology: time for a universal strategy

被引：32

作者：

Cheng, Michael L. ^{[1
]}

Berger, Michael F. ^{[2
,3
]}

Hyman, David M. ^{[1
]}

Solit, David B. ^{[1
,3
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA

[3] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA

来源：

NATURE REVIEWS CANCER | 2018年 / 18卷 / 09期

关键词：

SOLID TUMORS; CANCERS; INHIBITION;

D O I：

10.1038/s41568-018-0043-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Routine, comprehensive molecular characterization of patient tumours has the potential to accelerate therapeutic advances and inform cancer biology. Here, we describe insights from the implementation of an enterprise-wide, prospective clinical sequencing strategy at an academic cancer centre.

引用

页码：527 / 528

页数：2

共 19 条

[1] Precision oncology: a strategy we were not ready to deploy
Fojo, Tito
SEMINARS IN ONCOLOGY, 2016, 43 (01) : 9 - 12
[2] Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study
Zivanovic Bujak, Andjelija
Weng, Chen-Fang
Silva, Maria Joao
Yeung, Miriam
Lo, Louisa
Ftouni, Sarah
Litchfield, Cassandra
Ko, Yi-An
Kuykhoven, Keilly
Van Geelen, Courtney
Chandrashekar, Sushma
Dawson, Mark A.
Loi, Sherene
Wong, Stephen Q.
Dawson, Sarah-Jane
PLOS MEDICINE, 2020, 17 (10)
[3] The Role of Next-Generation Sequencing in Precision Medicine: A Review of Outcomes in Oncology
Morash, Margaret
Mitchell, Hannah
Beltran, Himisha
Elemento, Olivier
Pathak, Jyotishman
JOURNAL OF PERSONALIZED MEDICINE, 2018, 8 (03):
[4] Precision Oncology: Evolving Clinical Trials across Tumor Types
Song, I-Wen
Vo, Henry Hiep
Chen, Ying-Shiuan
Baysal, Mehmet A.
Kahle, Michael
Johnson, Amber
Tsimberidou, Apostolia M.
CANCERS, 2023, 15 (07)
[5] Clinical Utility of Precision Medicine in Pediatric Oncology: A Systematic Review
Lee, Justin
Gillam, Lynn
Visvanathan, Keshini
Hansford, Jordan R.
McCarthy, Maria C.
JCO PRECISION ONCOLOGY, 2021, 5 : 1088 - 1102
[6] Bioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trial
Servant, Nicolas
Romejon, Julien
Gestraud, Pierre
La Rosa, Philippe
Lucotte, Georges
Lair, Severine
Bernard, Virginie
Zeitouni, Bruno
Coffin, Fanny
Jules-Clement, Gerome
Yvon, Florent
Lermine, Alban
Poullet, Patrick
Liva, Stephane
Pook, Stuart
Popova, Tatiana
Barette, Camille
Prud'homme, Franois
Dick, Jean-Gabriel
Kamal, Maud
Le Tourneau, Christophe
Barillot, Emmanuel
Hupe, Philippe
FRONTIERS IN GENETICS, 2014, 5
[7] Next-generation sequencing-based clinical sequencing: toward precision medicine in solid tumors
Wakai, Toshifumi
Prasoon, Pankaj
Hirose, Yuki
Shimada, Yoshifumi
Ichikawa, Hiroshi
Nagahashi, Masayuki
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (02) : 115 - 122
[8] Next-generation sequencing-based clinical sequencing: toward precision medicine in solid tumors
Toshifumi Wakai
Pankaj Prasoon
Yuki Hirose
Yoshifumi Shimada
Hiroshi Ichikawa
Masayuki Nagahashi
International Journal of Clinical Oncology, 2019, 24 : 115 - 122
[9] The Landscape of Pediatric Precision Oncology: Program Design, Actionable Alterations, and Clinical Trial Development
Langenberg, Karin P. S.
Looze, Eleonora J.
Molenaar, Jan J.
CANCERS, 2021, 13 (17)
[10] Implementing the European Society for Medical Oncology Scale for Clinical Actionability of Molecular Targets in a Comprehensive Profiling Program: Impact on Precision Medicine Oncology
Martin-Romano, Patricia
Mezquita, Laura
Hollebecque, Antoine
Lacroix, Ludovic
Rouleau, Etienne
Gazzah, Anas
Bahleda, Rastilav
Planchard, David
Varga, Andrea
Baldini, Capucine
Postel-Vinay, Sophie
Friboulet, Luc
Loriot, Yohann
Verlingue, Loic
Geraud, Arthur
Camus, Maud Ngo
Nicotra, Claudio
Soria, Jean Charles
Andre, Fabrice
Besse, Benjamin
Massard, Christophe
Italiano, Antoine
JCO PRECISION ONCOLOGY, 2022, 6

← 1 2 →